Zetonna (ciclesonide nasal aerosol)
/ Sumitomo Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
April 14, 2021
Drugs for allergic rhinitis and allergic conjunctivitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Allergic Rhinitis • Allergy • Conjunctivitis • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
April 14, 2021
Comparison table: Some nasal sprays for allergic rhinitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Allergic Rhinitis • Allergy • Immunology
September 16, 2020
Nip it in the bud: New study will attack SARS-Cov2 where it multiplies
(MUHC)
- "...they started testing the efficiency of ciclesonide, an inhaled and nasal steroid drug....This placebo-controlled randomized trial will confirm if the administration of inhaled and nasal ciclesonide can reduce the severity of respiratory symptoms among mild cases of COVID-19 and potentially avoid the need for hospitalization and oxygen....The study enrolls adults diagnosed with COVID-19 fewer than 5 days prior to enrollment....Participants are randomly assigned the study drug or placebo in the form of an inhaler and nasal spray..."
Trial status • Infectious Disease • Novel Coronavirus Disease
February 20, 2019
Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
(PubMed, Otolaryngol Head Neck Surg)
- "While a differential effect on epistaxis among INCS agents is not clearly demonstrated, this meta-analysis does confirm an increased risk of epistaxis for patients using INCSs as compared with placebo for treatment of allergic rhinitis."
Journal • Retrospective data • Review
1 to 4
Of
4
Go to page
1